# Randomized Control Trial (RCT) of Transarterial Chemoembolization (TACE) Versus TACE and Oral Drug Therapy in the Treatment of Unresectable Hepatocellular Carcinoma

> **NCT00522405** · PHASE2,PHASE3 · UNKNOWN · sponsor: **All India Institute of Medical Sciences**

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **PROCEDURE:** TACE

## Key facts

- **NCT ID:** NCT00522405
- **Lead sponsor:** All India Institute of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-10
- **Primary completion:** 2014-08
- **Final completion:** 2014-10
- **Target enrollment:** — (—)
- **Last updated:** 2012-07-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00522405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00522405, "Randomized Control Trial (RCT) of Transarterial Chemoembolization (TACE) Versus TACE and Oral Drug Therapy in the Treatment of Unresectable Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00522405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*